title: Anthralin/dithranol in dermatology.
abstract: Anthralin (1,8-dihydroxy-9anthrone, dithranol) was first synthesized as a derivative of chrysarobin, prepared from the araroba tree in Brazil over a century ago. Drawbacks to the use of anthralin include irritation and discoloration of the skin. This property of the molecule prompted workers to investigate details of its pharmacology, mode of action, and indications. The major point of this article is to highlight and revisit these aspects for pertinent future use. Therefore, it is worthwhile to consider that the drug is relatively innocuous, yet effective, and is devoid of any systemic side effects in contrast to a wide variety of systemic and topical therapies available for psoriasis and other dermatoses.
authors.affiliation: Dermato-Venereology (Skin/VD) Center, Sehgal Nursing Home, Panchwati, Delhi Department of Dermatology and STD, University College of Medical Sciences, and Associated Guru Teg Bahadur Hospital, Shahdara, Delhi, India.
authors.forename: Virendra N
authors.initials: VN
authors.lastname: Sehgal
authors.forename: Prashant
authors.initials: P
authors.lastname: Verma
authors.forename: Ananta
authors.initials: A
authors.lastname: Khurana
mesh_terms: D000875:Anthralin / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D012871:Skin Diseases / Q000188:drug therapy*
chemical_list: D000875:Anthralin